Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win Read more
Leo ‘really strengthening’ pipeline with $435M deal for Tanabe rare skin disease drug awaiting FDA nod Read more
Regeneron ends eye disease trial for anti-CD3 antibody following safety review Read more
March 18, 2025 @ 12:00 am - March 19, 2025 @ 12:00 am

Europe’s largest cell and gene therapy conference and exhibition brings together senior leaders from pioneering ATMP companies, exploring the latest technologies and strategies shaping the future of the industry. The Advanced Therapies Congress will feature 10 content tracks, showcasing developments across the entire value chain of cell and gene therapy.
With over 100 solution providers and more than 12 hours of dedicated networking, the event offers unparalleled opportunities for collaboration and insight. Topics will cover gene therapy, cell therapy, viral vector manufacturing, clinical trials, gene editing, immunotherapy, and much more. Join industry experts in London this March to stay at the forefront of cell and gene therapy advancements.